Compassionate Use
Access to Unapproved Medicines in Urgent
and Life-Threatening Situations
and Life-Threatening Situations
What Is Compassionate Use?
Compassionate Use (also known as Expanded Access in some regions) refers to the provision of a medicine that:
- Is still under development or awaiting approval
- Is not commercially available in the patient’s country
- May offer potential benefit where no alternatives exist
- Is requested for a specific group of patients or even one individual
These programmes are often authorised by national Ministries of Health or ethics committees, and require strict eligibility and documentation.
How it works
We work alongside manufacturers, treating physicians, and national regulators to ensure Compassionate Use is handled with sensitivity, precision, and full legal alignment.
Problem:
When patients face serious or life-threatening conditions — and no approved treatment is available.
Solution
Compassionate Use Programmes may offer a path forward.
At COREX, we support ethical and compliant access to investigational or unlicensed medicines in cases where time is critical, and options are limited.
How COREX Supports Compassionate Use Supply
Importation & Customs Clearance of Unapproved Medicines
GxP-Compliant Storage & Temperature-Controlled Delivery
Documentation Handling & Regulatory Liaison
Support for Individual or Cohort-Based Access
Project Management Aligned With Ethics and Urgency
COREX Global Network
Ensuring seamless clinical supply solutions with local expertise and global reach.